ICUI
Get informed when a big investor buys or sells
+ FollowOvervalued by 10.1% based on the discounted cash flow analysis.
| Market cap | $4.61 Billion |
|---|---|
| Enterprise Value | $5.55 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.03 |
| Beta | 0.76 |
| Outstanding Shares | 25,000,000 |
| P/E Ratio | 153.8 |
|---|---|
| PEG | -334.44 |
| Price to Sales | 2.13 |
| Price to Book Ratio | 2.13 |
| Enterprise Value to Revenue | 2.57 |
| Enterprise Value to EBIT | 74.41 |
| Enterprise Value to Net Income | 145 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 0.58 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 63.01% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 27.24%▼ 74.23% |
|---|---|
| Total Invested | $988.91M▼ 69.33% |
| Investors Holding | 117▼ 165.00% |
No data
ICU Medical, Inc. is a San Clemente, California-based company with global operations that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical’s products a...